pregnancy, she experienced preterm labor and premature rupture of membranes with delivery of a previable infant at 5 months. Her second pregnancy ended in spontaneous abortion at 7 weeks. Current other medical conditions include obesity, chronic kidney disease, benign essential hypertension, and prediabetes. She has a history of abnormal cervical cytology smears and was treated with colposcopy and a loop electrosurgical excision procedure, which was followed by successive normal cytology exams. Because of her history of pregnancy complications and short cervical length (Ͻ2 cm), her current pregnancy was managed with placement of a prophylactic McDonald cerclage at the gestational age of 21 weeks. The cerclage was removed at gestational age 37 weeks. The mother was monitored for slow fetal growth in the third trimester that was suspected to be due to placental insufficiency. A vaginorectal culture taken at 39 weeks for Streptococcus agalactiae (group B Streptococcus) grew a betahemolytic organism with a wide zone of hemolysis ( Fig. 1 ). Gram staining showed Gram-positive cocci in pairs and short chains ( Fig. 1 ), and the organism was catalase negative and pyrrolidonyl arylamidase (PYR) negative and produced a weak positive reaction with the group B latex typing reagent in the PathoDx Strep grouping kit (Diagnostic Products Corporation, Los Angeles, CA, USA). Because the wide zone of beta-hemolysis was not consistent with S. agalactiae, the isolate was analyzed using Vitek MS matrix-assisted laser desorption-ionization time of flight mass spectrometry (MALDI-TOF MS) (bioMérieux, Durham, NC, USA), which returned a nonclinically validated identification of Streptococcus porcinus, with a confidence score of 99.9% generated using IVD Knowledge Base version 2.0 and Myla version 4 information management software. These data supported an identification of S. pseudoporcinus rather than S. porcinus.
The patient required Cesarean delivery at the gestational age of 39.3 weeks after failed induction of labor for severe gestational hypertension/preeclampsia. In this case, there was no premature rupture of membranes, and no intrapartum antibiotics were administered. On gross examination, the placenta weighed 383 g (Ͻ10th percentile for gestational age) and had increased perivillous fibrin. Both the patient and the infant did well subsequently.
DISCUSSION
Streptococcus porcinus is a beta-hemolytic Streptococcus species with Lancefield group NG1 (A1, C1), NG2, NG3, E, P, U, or V antigen, although some strains may be untypeable (1) . It was first isolated from swine in 1937 and was later found to be associated with sheep, rabbits, dogs, guinea pigs, and cattle. In pigs, S. porcinus has been shown to colonize the genital and upper respiratory tracts and is implicated in cellulitis, endocarditis, sepsis, cervical lymphadenitis, and spontaneous abortion (1, 2) .
Human sources of what appeared to be S. porcinus were first described in 1995. In 2005, Duarte et al. used randomly amplified polymorphic DNA-PCR and pulsed-field gel electrophoresis analyses to show that these human isolates differed from isolates obtained from animal sources, with the majority of the human strains containing NG1 antigen (3) . Subsequently, analysis of 16S rRNA gene sequence data of several human isolates recovered from female genitourinary tract specimens phenotypically described as S. porcinus revealed the sequences to be Ͼ2% dissimilar to any other Streptococcus species and thus highly suggestive of a novel species (4). These findings led to the creation of a new species termed Streptococcus pseudoporcinus.
S. pseudoporcinus is a facultative, nonmotile, Gram-positive coccus that produces smooth, round-to-oval, beta-hemolytic colonies on blood agar ( Fig. 1) and may possess E, P, or NG1 antigen or be untypeable (1, 3, 5) . Like S. agalactiae, S. pseudoporcinus produces large colonies (typically Ͼ0.5 mm) after 24 h of incubation (which is useful for differentiating beta-hemolytic streptococci prior to Lancefield antigen typing because it excludes the possibility of beta-hemolytic strains of members of the Streptococcus anginosus group, whose colonies are characteristically smaller [Յ0.5 mm]), is CAMP factor positive, and is bacitracin resistant, and both species are most commonly isolated from the female genitourinary tract (1, 2) . Although, unlike S. agalactiae, S. pseudoporcinus does not contain Lancefield group B antigen, it cross-reacts with group B antigen agglutination reagents in Streptococcus serogrouping kits (1, (4) (5) (6) (7) (8) . Furthermore, colonies of S. pseudoporcinus have been reported as indistinguishable from those of S. agalactiae when chromogenic agars designed for the detection of S. agalactiae are utilized (6) . Taken together, this can make differentiation between S. pseudoporcinus and S. agalactiae difficult and has probably led to an underestimation of the former's role and frequency in human colonization and disease. Frequency may also be underestimated because molecular screening tests to detect S. agalactiae do not detect S. pseudoporcinus (6) .
In contrast to S. agalactiae, which displays a narrow zone of beta-hemolysis, S. pseudoporcinus exhibits a large zone (Fig. 1) . Additionally, S. agalactiae is esculin hydrolysis negative and hippurate hydrolysis positive and does not ferment sorbitol or mannitol, while the opposite is true for S. pseudoporcinus (1, 3, 4) . Also, S. agalactiae is PYR negative, while some varied PYR results have been reported for S. pseudoporcinus and S. porcinus (4) . Finally, while MALDI-TOF MS is a robust and reliable identification tool, it produced an identification of S. porcinus in this case since the closely related S. pseudoporcinus is not included in the Vitek MS knowledge database but is planned for a future version. As a point of reference, our isolate when analyzed using the Bruker Biotyper platform (Bruker Daltonics, Billerica, MA) and prepared using the extended direct transfer method (application of the organism to the target and overlay with 70% [vol/vol] formic acid prior to addition of matrix) was identified as S. porcinus, with a log(score) value of 1.914 (probable genus identification) using the research-use-only database (RUO6903). When prepared using the ethanol-formic acid extraction method to increase the efficiency of protein extraction, the isolate was identified as S. porcinus with a log(score) value of 2.142 (secure genus identification, probable species identification), again using the RUO6903 database.
Though little is known about the pathogenicity of S. pseudoporcinus in human disease, the literature suggests the possibility of adverse obstetric outcomes. For example, while it has not been implicated as a cause of neonatal sepsis, it has been associated with chorioamnionitis and preterm delivery (1) . The underlying pathophysiology appears to be cervical as opposed to uterine. Some studies suggest that an ascending S. pseudoporcinus infection may trigger an inflammatory cascade, leading to cervical and amniotic membrane microarchitecture remodeling and ultimately leading to cervical insufficiency or premature rupture of membranes (8) . Although the clinical significance of S. pseudoporcinus has not been completely established, we report the identification when we recover the organism from S. agalactiae screening cultures. It may actually be more useful when it is detected early in pregnancy, since some of the conditions potentially attributed to this bacterium, such as chorioamnionitis, can be experienced as early as the first trimester.
The acquisition of S. pseudoporcinus has been independently associated with black women, aged 21 to 43 years, who have ever reported genital herpes simplex virus infection, recent Trichomonas vaginalis infection, bacterial vaginosis by the Nugent criteria, or obesity or who have had two or more male sexual partners during the 1 or 2 months since their last health clinic visit (i.e., increased numbers of sexual partners) (1, 6) . Therefore, based on some of these findings, it has been suggested that S. pseudoporcinus may be associated with sexually transmitted infections (STIs). S. pseudoporcinus is exquisitely susceptible to beta-lactam antibiotics, vancomycin, and trimethoprim-sulfamethoxazole but has a high rate of resistance to tetracycline (1, 3, 7) . Although some isolates of S. pseudoporcinus are resistant to erythromycin and clindamycin, significantly higher rates of resistance have been observed with S. agalactiae (1, 3, 5, 7) .
In conclusion, the increase in the number of isolates identified as S. pseudoporcinus is most likely related to improvements in identification methods and greater awareness of this organism rather than its recent emergence in the human population (5) . The association between S. pseudoporcinus and ethnicity, STIs, and adverse obstetrical outcomes warrants further investigation. Controlled studies in which microbiologic testing is performed to distinguish between S. agalactiae and S. pseudoporcinus are needed in order to determine if the latter is consistently identified as the true causative agent in morbid pregnancy-related outcomes.
